12 Health Care Stocks Moving In Tuesday's Pre-Market Session

 

Gainers

  • Allarity Therapeutics ALLR stock rose 16.4% to $1.42 during Tuesday's pre-market session. The company's market cap stands at $13.1 million.
  • Vaccinex VCNX stock rose 12.91% to $1.15. The company's market cap stands at $49.1 million.
  • Avalo Therapeutics AVTX shares moved upwards by 12.49% to $4.05. The market value of their outstanding shares is at $38.0 million.
  • Harmony Biosciences HRMY shares moved upwards by 10.25% to $54.28. The market value of their outstanding shares is at $3.2 billion. As per the news, the Q2 earnings report came out today.
  • Sonnet BioTherapeutics SONN shares increased by 9.84% to $0.3. The company's market cap stands at $18.1 million.
  • AdaptHealth AHCO stock increased by 9.5% to $24.42. The market value of their outstanding shares is at $3.2 billion.

Losers

  • Eliem Therapeutics ELYM stock decreased by 25.3% to $2.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $60.3 million.
  • Syneos Health SYNH shares declined by 13.45% to $68.5. The market value of their outstanding shares is at $7.0 billion. As per the news, the Q2 earnings report came out today.
  • Reviva Pharmaceuticals RVPH shares fell 12.0% to $0.66. The market value of their outstanding shares is at $9.9 million.
  • Enhabit EHAB shares decreased by 11.02% to $15.99. The market value of their outstanding shares is at $797.8 million. The company's, Q2 earnings came out yesterday.
  • IMAC Holdings IMAC stock declined by 10.89% to $0.9. The company's market cap stands at $23.8 million.
  • HTG Molecular Diagnostics HTGM stock fell 10.24% to $0.94. The company's market cap stands at $10.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!